Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Human Genetics, |
RCV001263010 | SCV001441082 | uncertain significance | Malignant hyperthermia, susceptibility to, 1 | 2019-01-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001880052 | SCV002234070 | uncertain significance | RYR1-related disorder | 2024-01-27 | criteria provided, single submitter | clinical testing | This sequence change replaces isoleucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 1227 of the RYR1 protein (p.Ile1227Val). This variant is present in population databases (rs746166976, gnomAD 0.003%). This missense change has been observed in individual(s) with clinical features of RYR1-related conditions (PMID: 30325262). ClinVar contains an entry for this variant (Variation ID: 983142). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt RYR1 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
All of Us Research Program, |
RCV001263010 | SCV004820817 | uncertain significance | Malignant hyperthermia, susceptibility to, 1 | 2023-08-15 | criteria provided, single submitter | clinical testing |